Literature DB >> 28617943

Long-term impact of childhood selective dorsal rhizotomy on pain, fatigue, and function: a case-control study.

Alecia K Daunter1, Anna L Kratz1, Edward A Hurvitz1.   

Abstract

AIM: Selective dorsal rhizotomy (SDR) is a surgical treatment for spasticity in children with cerebral palsy (CP). Studies suggest long-lasting effects of SDR on spasticity; long-term effects on symptoms and function are not clear. This study tested whether adults with CP (average 22y after SDR) report less pain, fatigue, and functional decline than a retrospectively assessed non-surgical comparison group.
METHOD: This was a case-control study. Eighty-eight adults with CP (mean age 27y; SDR=38 male/female/missing=20/16/2; non-surgical [comparison]=50, male/female=19/31) recruited from a tertiary care center and the community completed a battery of self-reported outcome measures. Regression models were used to test whether SDR status predicted pain, fatigue, functional change, and hours of assistance (controlling for Gross Motor Function Classification System level).
RESULTS: SDR status did not significantly predict pain interference (p=0.965), pain intensity (p=0.512), or fatigue (p=0.404). SDR related to lower decline in gross motor functioning (p=0.010) and approximately 6 fewer hours of daily assistance than for those in the comparison group (p=0.001).
INTERPRETATION: Adults with CP who had SDR in childhood reported less gross motor decline and fewer daily assistance needs than non-surgically treated peers, suggesting the functional impact of SDR persists long after surgery.
© 2017 Mac Keith Press.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28617943      PMCID: PMC5610610          DOI: 10.1111/dmcn.13481

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  24 in total

1.  Fatigue in adults with cerebral palsy in Norway compared with the general population.

Authors:  Reidun Jahnsen; Lisbeth Villien; Johan K Stanghelle; Inger Holm
Journal:  Dev Med Child Neurol       Date:  2003-05       Impact factor: 5.449

2.  The reliability of a self-reported measure of disease, impairment, and function in persons with spinal cord dysfunction.

Authors:  H Hoenig; L McIntyre; R Sloane; L G Branch; A Truncali; R D Horner
Journal:  Arch Phys Med Rehabil       Date:  1998-04       Impact factor: 3.966

3.  Functional decline in children undergoing selective dorsal rhizotomy after age 10.

Authors:  Bruce A MacWilliams; Barbara A Johnson; Amy L Shuckra; Jacques L D'Astous
Journal:  Dev Med Child Neurol       Date:  2011-06-17       Impact factor: 5.449

4.  Predictors for the benefit of selective dorsal rhizotomy.

Authors:  Julia F Funk; Amelie Panthen; M Sinan Bakir; Franziska Gruschke; Akosua Sarpong; Christiane Wagner; Susanne Lebek; Ernst Johannes Haberl
Journal:  Res Dev Disabil       Date:  2014-11-29

5.  The evolution of gait in childhood and adolescent cerebral palsy.

Authors:  D C Johnson; D L Damiano; M F Abel
Journal:  J Pediatr Orthop       Date:  1997 May-Jun       Impact factor: 2.324

6.  Does loss of spasticity matter? A 10-year follow-up after selective dorsal rhizotomy in cerebral palsy.

Authors:  Kristina Tedroff; Kristina Löwing; Dan N O Jacobson; Eva Åström
Journal:  Dev Med Child Neurol       Date:  2011-05-18       Impact factor: 5.449

7.  Recent trends in cerebral palsy survival. Part I: period and cohort effects.

Authors:  Jordan C Brooks; David J Strauss; Robert M Shavelle; Linh M Tran; Lewis Rosenbloom; Yvonne W Wu
Journal:  Dev Med Child Neurol       Date:  2014-06-26       Impact factor: 5.449

8.  Pain in persons with cerebral palsy: extension and cross validation.

Authors:  Joyce M Engel; Mark P Jensen; Amy J Hoffman; Deborah Kartin
Journal:  Arch Phys Med Rehabil       Date:  2003-08       Impact factor: 3.966

9.  Performance of adults with cerebral palsy related to falls, balance and function: a preliminary report.

Authors:  P Morgan; J McGinley
Journal:  Dev Neurorehabil       Date:  2013       Impact factor: 2.308

10.  Functional outcomes of childhood dorsal rhizotomy in adults and adolescents with cerebral palsy.

Authors:  Edward A Hurvitz; Christina M Marciniak; Alecia K Daunter; Heidi J Haapala; Stacy M Stibb; Sarah F McCormick; Karin M Muraszko; Deborah Gaebler-Spira
Journal:  J Neurosurg Pediatr       Date:  2013-02-08       Impact factor: 2.375

View more
  6 in total

Review 1.  Selective dorsal rhizotomy: current state of practice and the role of imaging.

Authors:  David Graham; Kristian Aquilina; Kshitij Mankad; Neil Wimalasundera
Journal:  Quant Imaging Med Surg       Date:  2018-03

2.  Efficacy of Selective Dorsal Rhizotomy and Intrathecal Baclofen Pump in the Management of Spasticity.

Authors:  Pramath Kakodkar; Hidy Girgis; Perla Nabhan; Sharini Sam Chee; Albert Tu
Journal:  Adv Tech Stand Neurosurg       Date:  2022

Review 3.  Interventional Approaches to Pain and Spasticity Related to Cerebral Palsy.

Authors:  Jacquelin Peck; Ivan Urits; Hisham Kassem; Christopher Lee; Wilton Robinson; Elyse M Cornett; Amnon A Berger; Jared Herman; Jai Won Jung; Alan D Kaye; Omar Viswanath
Journal:  Psychopharmacol Bull       Date:  2020-10-15

4.  Australian children undergoing selective dorsal rhizotomy: protocol for a national registry of multidimensional outcomes.

Authors:  Jennifer Lewis; Natasha Bear; Felicity Baker; Adam Fowler; Olivia Lee; Kim McLennan; Emma Richardson; Adam Scheinberg; Nadine Smith; Pam Thomason; Andrew Tidemann; Meredith Wynter; Simon Paget
Journal:  BMJ Open       Date:  2019-05-01       Impact factor: 2.692

Review 5.  Long-term effects of selective dorsal rhizotomy in children with cerebral palsy: a systematic review.

Authors:  Kristina Tedroff; Gunnar Hägglund; Freeman Miller
Journal:  Dev Med Child Neurol       Date:  2019-07-24       Impact factor: 5.449

6.  Selective dorsal rhizotomy in ambulant children with cerebral palsy.

Authors:  K K Wang; M E Munger; B P-J Chen; T F Novacheck
Journal:  J Child Orthop       Date:  2018-10-01       Impact factor: 1.548

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.